Insiders EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
12.09 ^USD	-4.58%		-38.75%	-47.68%

08/05	Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating	MT
08/05	Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board	02/04	CI
EyePoint Pharmaceuticals Names Ramiro Ribeiro Chief Medical Officer	05/03	MT
EyePoint Pharmaceuticals, Inc. Announces Executive Changes	04/03	CI
Eyepoint Pharmaceuticals Insider Sold Shares Worth $1,265,539, According to a Recent SEC Filing	31/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $660,370, According to a Recent SEC Filing	30/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $297,621, According to a Recent SEC Filing	27/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $409,790, According to a Recent SEC Filing	26/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $795,191, According to a Recent SEC Filing	25/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $484,124, According to a Recent SEC Filing	11/01	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $19,510,637, According to a Recent SEC Filing	08/12	MT
EyePoint Pharmaceuticals Insider Sold Shares Worth $19,510,637, According to a Recent SEC Filing	08/12	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $990,000, According to a Recent SEC Filing	07/12	MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $415,200, According to a Recent SEC Filing	07/12	MT
EyePoint Pharmaceuticals, Inc. Announces Executive Changes	16/23/16	CI
Akari Therapeutics Names Wendy DiCicco Interim Finance Chief	19/23/19	MT
EyePoint Pharmaceuticals Names Jay Duker CEO; Shares Climb	11/23/11	MT
EyePoint Pharmaceuticals Names Jay Duker CEO	10/23/10	MT
Eyepoint Pharmaceuticals, Inc. Announces Chief Executive Officer Changes	10/23/10	CI
Eyepoint Pharmaceuticals, Inc. Announces Executive Changes	10/23/10	CI
Eyepoint Pharmaceuticals Promotes Jay S. Duker, M.D. to President and Chief Operating Officer	04/23/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Insiders

Filters